Packages of care for epilepsy in low- and middle-income countries

Caroline K Mbuba, Charles R Newton, Caroline K Mbuba, Charles R Newton

Abstract

In the second in a series of six articles on packages of care for mental health disorders in low- and middle-income countries, Caroline Mbuba and Charles Newton discuss treatment for epilepsy.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. World Health Organisation (WHO) Atlas: epilepsy care in the world. Geneva: WHO; 2005.
    1. Ngugi AK, Bottomly C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2009 In press.
    1. Kale R. Global Campaign Against Epilepsy: the treatment gap. Epilepsia. 2002;43:31–33.
    1. Diop AG, Hesdorffer DC, Logroscino G, Hauser WA. Epilepsy and mortality in Africa: a review of the literature. Epilepsia. 2005;46(Suppl 11):33–35.
    1. Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008;49:1491–1503.
    1. WHO. Diseases of the nervous system. International classification of diseases and related health problems. Geneva: WHO; 2007. pp. G00–G99.
    1. Fisher RS, van Emde BW, Blume W, Elger C, Genton P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470–472.
    1. ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489–501.
    1. Fisher RS, Vickrey BG, Gibson P, Hermann B, Penovich P, et al. The impact of epilepsy from the patient's perspective I. Descriptions and subjective perceptions. Epilepsy Res. 2000;41:39–51.
    1. LaFrance WC, Jr, Kanner AM, Hermann B. Psychiatric comorbidities in epilepsy. Int Rev Neurobiol. 2008;83:347–383.
    1. Baker GA. The psychosocial burden of epilepsy. Epilepsia. 2002;43(Suppl 6):26–30.
    1. Devinsky O. Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment. Epilepsy Behav. 2003;4(Suppl 4):S2–S10.
    1. Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110:207–220.
    1. Nubukpo P, Preux PM, Houinato D, Radji A, Grunitzky EK, et al. Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) I. Anxiety and depression measured using Goldberg's scale. Epilepsy Behav. 2004;5:722–727.
    1. Baskind R, Birbeck GL. Epilepsy-associated stigma in sub-Saharan Africa: the social landscape of a disease. Epilepsy Behav. 2005;7:68–73.
    1. Birbeck G, Chomba E, Atadzhanov M, Mbewe E, Haworth A. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol. 2007;6:39–44.
    1. Chowdhury FA, Nashef L, Elwes RD. Misdiagnosis in epilepsy: a review and recognition of diagnostic uncertainty. Eur J Neurol. 2008;15:1034–1042.
    1. Dooley JM, Gordon KE, Wood EP, Camfield CS, Camfield PR. The utility of the physical examination and investigations in the pediatric neurology consultation. Pediatr Neurol. 2003;28:96–99.
    1. Bernal B, Altman NR. Evidence-based medicine: neuroimaging of seizures. Neuroimaging Clin N Am. 2003;13:211–224.
    1. Wieshmann UC. Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg Psychiatry. 2003;74:466–470.
    1. Duncan JS. Neuroimaging methods to evaluate the etiology and consequences of epilepsy. Epilepsy Res. 2002;50:131–140.
    1. Kwan P, Sander JW. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry. 2004;75:1376–1381.
    1. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094–1120.
    1. Taylor S, Tudur SC, Williamson PR, Marson AG. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev. 2001:CD002217.
    1. TudurSmith C, Marson AG, Williamson PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev. 2001:CD001769.
    1. TudurSmith C, Marson AG, Clough HE, Williamson PR. Carbamazepine versus phenytoin monotherapy for epilepsy. Cochrane Database Syst Rev. 2002:CD001911.
    1. TudurSmith C, Marson AG, Williamson PR. Carbamazepine versus phenobarbitone monotherapy for epilepsy. Cochrane Database Syst Rev. 2003:CD001904.
    1. Placencia M, Sander JW, Shorvon SD, Roman M, Alarcon F, et al. Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res. 1993;14:237–244.
    1. Feksi AT, Kaamugisha J, Sander JW, Gatiti S, Shorvon SD. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. Lancet. 1991;337:406–409.
    1. Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet. 1998;351:19–23.
    1. Scott RA, Lhatoo SD, Sander JW. The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ. 2001;79:344–351.
    1. ILAE. Availability and distribution of antiepileptic drugs in developing countries. III and IV Commissions on Antiepileptic Drugs of the International League Against Epilepsy. Epilepsia. 1985;26:117–121.
    1. Tonini C, Beghi E, Berg AT, Bogliun G, Giordano L, et al. Predictors of epilepsy surgery outcome: a meta-analysis. Epilepsy Res. 2004;62:75–87.
    1. Asadi-Pooya AA, Sperling MR. Strategies for surgical treatment of epilepsies in developing countries. Epilepsia. 2008;49:381–385.
    1. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002;1:477–482.
    1. Arida RM, Cavalheiro EA, da Silva AC, Scorza FA. Physical activity and epilepsy: proven and predicted benefits. Sports Med. 2008;38:607–615.
    1. Kossoff EH. International consensus statement on clinical implementation of the ketogenic diet: agreement, flexibility, and controversy. Epilepsia. 2008;49(Suppl 8):11–13.
    1. Seo JH, Kim HD. Cultural challenges in using the ketogenic diet in Asian countries. Epilepsia. 2008;49(Suppl 8):50–52.
    1. Ramaratnam S, Baker GA, Goldstein LH. Psychological treatments for epilepsy. Cochrane Database Syst Rev. 2008:CD002029.
    1. Mielke J, Adamolekun B, Ball D, Mundanda T. Knowledge and attitudes of teachers towards epilepsy in Zimbabwe. Acta Neurol Scand. 1997;96:133–137.
    1. Mani KS, Rangan G, Srinivas HV, Srindharan VS, Subbakrishna DK. Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet. 2001;357:1316–1320.
    1. Beghi E. Injuries in patients with epilepsy. Lancet Neurol. 2005;4:71–72.
    1. Josty IC, Narayanan V, Dickson WA. Burns in patients with epilepsy: changes in epidemiology and implications for burn treatment and prevention. Epilepsia. 2000;41:453–456.
    1. Jilek-Aall L. Morbus sacer in Africa: some religious aspects of epilepsy in. Epilepsia. 1999;40:382–386.
    1. Adamolekun B, Mielke JK, Ball DE. An evaluation of the impact of health worker and patient education on the care and compliance of patients with epilepsy in Zimbabwe. Epilepsia. 1999;40:507–511.
    1. Gourie-Devi M, Satishchandra P, Gururaj G. Epilepsy control program in India: a district model. Epilepsia. 2003;44(Suppl 1):58–62.: 58–62.
    1. Olley BO. Psychosocial and seizure factors related to depression and neurotic-disorders among patients with chronic epilepsy in Nigeria. Afr J Med Med Sci. 2004;33:39–44.
    1. Usiskin SC. The role of counselling in an out-patient epilepsy clinic: a three year study. Seizure. 1993;2:111–114.
    1. Weiss MG, Ramakrishna J. Stigma interventions and research for international health. Lancet. 2006;367:536–538.
    1. Watts AE. A model for managing epilepsy in a rural community in Africa. BMJ. 1989;298:805–807.
    1. Berhanu S, Alemu S, Prevett M, Parry EH. Primary care treatment of epilepsy in rural Ethiopia: causes of default from follow-up. Seizure. 2009;18:100–103.
    1. Reynolds EH. The ILAE/IBE/WHO Global Campaign against Epilepsy: bringing epilepsy “out of the shadows”. Epilepsy Behav. 2000;1:S3–S8.
    1. Wang W, Wu J, Dai X, Ma G, Yang B, et al. Global campaign against epilepsy: assessment of a demonstration project in rural china. Bull World Health Organ. 2008:964–969.
    1. Whyte SR. Constructing epilepsy: images and contexts in East Africa. In: Whyte SR, Ingstad B, editors. Disability and culture. Berkeley: University of California Press; 1995. pp. 226–245.
    1. Baskind R, Birbeck G. Epilepsy care in Zambia: a study of traditional healers. Epilepsia. 2005;46:1121–1126.
    1. Kendall-Taylor N, Kathomi C, Rimba K, Newton CR. Traditional healers and epilepsy treatment on the Kenyan coast. Epilepsia. 2008;49:1638–1639.
    1. Pal DK, Das T, Sengupta S. Case-control and qualitative study of attrition in a community epilepsy programme in rural India. Seizure. 2000;9:119–123.
    1. Corey LA, Kjeldsen MJ, Solaas MH, Nakken KO, Friis ML, et al. The accuracy of self-reported history of seizures in Danish, Norwegian and U.S. twins. Epilepsy Res. 2009;84:1–5.
    1. Reutens DC, Howell RA, Gebert KE, Berkovic SF. Validation of a questionnaire for clinical seizure diagnosis. Epilepsia. 1992;33:1065–1071.
    1. Cockerell OC, Goodridge DM, Brodie D, Sander JW, Shorvon SD. Neurological disease in a defined population: the results of a pilot study in two general practices. Neuroepidemiology. 1996;15:73–82.
    1. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia. 1991;32:429–445.
    1. Placencia M, Sander JW, Shorvon SD, Ellison RH, Cascante SM. Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain. 1992;115:783–794.
    1. Preux PM. [Questionnaire in a study of epilepsy in tropical countries]. Bull Soc Pathol Exot. 2000;93:276–278.
    1. Sawhney IM, Lekhra OP, Shashi JS, Prabhakar S, Chopra JS. Evaluation of epilepsy management in a developing country: a prospective study of 407 patients. Acta Neurol Scand. 1996;94:19–23.
    1. Murthy JM, Yangala R, Srinivas M. The syndromic classification of the International League Against Epilepsy: a hospital-based study from South India. Epilepsia. 1998;39:48–54.
    1. Mohamed Y, Alias NN, Shuaib IL, Tharakan J, Abdullah J, et al. Referral of epileptic patients in North East Coast of West Malaysia an area with poor MRI coverage: an analysis. Southeast Asian J Trop Med Public Health. 2006;37:1199–1208.
    1. Banu SH, Jahan M, Koli UK, Ferdousi S, Khan NZ, et al. Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. BMJ. 2007;334:1207.
    1. Wang WZ, Wu JZ, Ma GY, Dai XY, Yang B, et al. Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol. 2006;5:46–52.
    1. Radhakrishnan K. Epilepsy surgery in India. Neurol India. 2009;57:4–6.
    1. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500–506.
    1. Helgeson DC, Mittan R, Tan SY, Chayasirisobhon S. Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia. 1990;31:75–82.
    1. Snead K, Ackerson J, Bailey K, Schmitt MM, Madan-Swain A, et al. Taking charge of epilepsy: the development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents. Epilepsy Behav. 2004;5:547–556.
    1. Helde G, Bovim G, Brathen G, Brodtkorb E. A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial. Epilepsy Behav. 2005;7:451–457.
    1. Liu L, Yiu CH, Yen DJ, Chou MH, Lin MF. Medication education for patients with epilepsy in Taiwan. Seizure. 2003;12:473–477.
    1. Lundgren T, Dahl J, Melin L, Kies B. Evaluation of acceptance and commitment therapy for drug refractory epilepsy: a randomized controlled trial in South Africa–a pilot study. Epilepsia. 2006;47:2173–2179.
    1. Dahl J, Melin L, Lund L. Effects of a contingent relaxation treatment program on adults with refractory epileptic seizures. Epilepsia. 1987;28:125–132.
    1. Adamolekun B, Mielke J, Ball D, Mundanda T. An evaluation of the management of epilepsy by primary health care nurses in Chitungwiza Zimbabwe. Epilepsy Res. 2000;39:177–181.
    1. Mani KS, Sidharta P, Pickering C. Educational aspects in the education of health workers, patients, and the public. Viewpoints from south India, Indonesia and Kenya. Trop Geogr Med. 1994;46:S34–S36.
    1. Mani KS, Subbakrishna DK. Perspectives from a developing nation with special reference to rural areas. Epilepsia. 2003;44(Suppl 1):55–7.: 55–57.
    1. Pal DK, Das T, Sengupta S, Chaudhury G. Help-seeking patterns for children with epilepsy in rural India: implications for service delivery. Epilepsia. 2002;43:904–911.
    1. Olley BO, Osinowo HO, Brieger WR. Psycho-educational therapy among Nigerian adult patients with epilepsy: a controlled outcome study. Patient Educ Couns. 2001;42:25–33.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi